Answers are grounded in this paper and cite their sources.
Analysis shows outpatient prescription charges vary significantly in metastatic colorectal cancer, indicating higher out-of-pocket expenses.
Estimated association of metastasis and other factors with the pre–post proportional increases in outpatient prescription charges and OOP expenses. Estimated relative ratio of proportional increase in pre– and post–colorectal cancer (CRC) prescription charges and OOP expenses associated with each factor, with 95% CIs, two-sided P value, and illustrative plots. Ref, reference. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: